A new breed of diagnostic companies is rolling out technologies to tackle a growing and deadly healthcare problem: antibiotic-resistant bugs
By Brian Gormley
A new breed of diagnostic companies is rolling out technologies to tackle a growing and deadly healthcare problem: antibiotic-resistant bugs.
More than 35,000 Americans die annually from drug-resistant bacterial and fungal infections, according to a November report from the Centers for Disease Control and Prevention. And 270,000 people die annually from sepsis, an overwhelming response to an infection, according to the National Institute of General Medical Sciences.
Visit this Wall Street Journal story at: www.wsj.com/articles/diagnostics-startups-take-on-growing-threat-of-antibiotic-resistant-bugs-11579005954
